Pharmanutra S.p.A. (BIT:PHN)

Italy flag Italy · Delayed Price · Currency is EUR
39.50
-0.70 (-1.74%)
Sep 26, 2025, 5:35 PM CET
-1.74%
Market Cap379.33M
Revenue (ttm)122.25M
Net Income (ttm)16.90M
Shares Out9.60M
EPS (ttm)1.76
PE Ratio22.46
Forward PE17.75
Dividend1.00 (2.53%)
Ex-Dividend DateMay 5, 2025
Volume20,265
Average Volume18,659
Open40.25
Previous Close40.20
Day's Range39.45 - 40.25
52-Week Range39.45 - 60.00
Beta0.32
RSI19.84
Earnings DateSep 8, 2025

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar... [Read more]

Sector Healthcare
Founded 2003
Employees 118
Stock Exchange Borsa Italiana
Ticker Symbol PHN
Full Company Profile

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.

Financial Statements

News

There is no news available yet.